[HTML][HTML] GLP-1 receptor agonists: beyond their pancreatic effects
X Zhao, M Wang, Z Wen, Z Lu, L Cui, C Fu… - Frontiers in …, 2021 - frontiersin.org
Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects.
X Zhao, M Wang, Z Wen, Z Lu, L Cui, C Fu… - Frontiers in …, 2021 - europepmc.org
Abstract Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor
agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
[HTML][HTML] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
X Zhao, Y Liu, Y Zhang - Frontiers in Endocrinology, 2021 - frontiersin.org
Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
[HTML][HTML] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
X Zhao, M Wang, Z Wen, Z Lu, L Cui, C Fu… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Abstract Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor
agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
agonists (GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
[引用][C] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
X Zhao, M Wang, Z Wen, Z Lu, L Cui, C Fu… - Frontiers in …, 2021 - jglobal.jst.go.jp
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects | Article Information | J-GLOBAL
Art J-GLOBAL ID:202102273716316790 Reference number:21A2822861 GLP-1 Receptor …
Art J-GLOBAL ID:202102273716316790 Reference number:21A2822861 GLP-1 Receptor …
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
X Zhao, M Wang, Z Wen, Z Lu, L Cui… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Glucagon like peptide-1 (GLP-1) is an incretin secretory molecule. GLP-1 receptor agonists
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …
(GLP-1RAs) are widely used in the treatment of type 2 diabetes (T2DM) due to their …